$IONQ
IonQ, Inc.

2022 Q4 Form 10-Q Financial Statement

#000119312522284614 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $3.807M $2.763M $233.0K
YoY Change 131.01% 1085.84%
Cost Of Revenue $901.0K $733.0K $234.0K
YoY Change 202.35% 213.25%
Gross Profit $2.906M $2.030M -$1.000K
YoY Change 115.26% -203100.0%
Gross Profit Margin 76.33% 73.47% -0.43%
Selling, General & Admin $11.48M $12.12M $3.747M
YoY Change 83.22% 223.41% 36962.31%
% of Gross Profit 395.01% 596.95%
Research & Development $13.70M $13.29M $6.180M
YoY Change 178.54% 115.08%
% of Gross Profit 471.3% 654.78%
Depreciation & Amortization $1.356M $1.100M $1.543M
YoY Change 34.93% -28.71%
% of Gross Profit 46.66% 54.19%
Operating Expenses $26.53M $25.41M $10.52M
YoY Change 117.7% 141.47% 103985.06%
Operating Profit -$23.63M -$24.91M -$10.52M
YoY Change 118.0% 136.71%
Interest Expense $3.167M $2.059M -$4.259M
YoY Change -148.34%
% of Operating Profit
Other Income/Expense, Net $1.811M $20.00K $2.000K
YoY Change -102.86% 900.0%
Pretax Income -$18.65M -$23.98M -$14.78M
YoY Change -74.83% 62.26% 146101.78%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.65M -$23.98M -$14.78M
YoY Change -74.83% 62.26% 146043.96%
Net Earnings / Revenue -489.81% -868.01% -6343.78%
Basic Earnings Per Share -$0.12 -$0.12
Diluted Earnings Per Share -$0.09 -$0.12 -$122.6K
COMMON SHARES
Basic Shares Outstanding 200.0M 199.2M 120.6M
Diluted Shares Outstanding 198.3M 120.6M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $355.8M $405.6M $587.3M
YoY Change -31.9% -30.93% 2349076.0%
Cash & Equivalents $44.37M $57.20M $587.3M
Short-Term Investments $311.4M $348.4M
Other Short-Term Assets $12.54M $8.134M $6.478M
YoY Change 94.64% 25.56%
Inventory
Prepaid Expenses $3.952M
Receivables $3.292M $2.876M $4.082M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $371.6M $416.6M $597.9M
YoY Change -29.83% -30.31% 2391316.0%
LONG-TERM ASSETS
Property, Plant & Equipment $26.01M $25.07M $20.83M
YoY Change 37.86% 20.35%
Goodwill $742.0K
YoY Change
Intangibles $8.944M $7.600M
YoY Change 53.12%
Long-Term Investments $182.0M $150.2M
YoY Change 127.19%
Other Assets $4.910M $3.315M $2.357M
YoY Change 38.0% 40.64% 751.76%
Total Long-Term Assets $226.4M $190.0M $28.71M
YoY Change 101.37% 561.76% 10273.3%
TOTAL ASSETS
Total Short-Term Assets $371.6M $416.6M $597.9M
Total Long-Term Assets $226.4M $190.0M $28.71M
Total Assets $598.0M $606.6M $626.6M
YoY Change -6.86% -3.19% 207562.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.055M $5.042M $1.967M
YoY Change 62.33% 156.33% 5911.61%
Accrued Expenses $6.655M $8.177M $4.047M
YoY Change 151.42% 102.05% 1551.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.16M $19.63M $11.08M
YoY Change 108.03% 77.24% 3761.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $303.0K $367.0K $57.82M
YoY Change -99.26% -99.37%
Total Long-Term Liabilities $303.0K $367.0K $57.82M
YoY Change -99.26% -99.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.16M $19.63M $11.08M
Total Long-Term Liabilities $303.0K $367.0K $57.82M
Total Liabilities $29.78M $30.97M $68.89M
YoY Change -41.37% -55.04% 23918.07%
SHAREHOLDERS EQUITY
Retained Earnings -$194.3M -$175.7M
YoY Change 33.27%
Common Stock $20.00K $20.00K
YoY Change 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $568.2M $575.6M $557.7M
YoY Change
Total Liabilities & Shareholders Equity $598.0M $606.6M $626.6M
YoY Change -6.86% -3.19% 207562.4%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$18.65M -$23.98M -$14.78M
YoY Change -74.83% 62.26% 146043.96%
Depreciation, Depletion And Amortization $1.356M $1.100M $1.543M
YoY Change 34.93% -28.71%
Cash From Operating Activities -$14.91M -$12.86M -$20.16M
YoY Change 218.25% -36.22%
INVESTING ACTIVITIES
Capital Expenditures $1.406M -$1.587M -$5.714M
YoY Change -152.29% -72.23%
Acquisitions
YoY Change
Other Investing Activities $6.557M $26.56M -$1.200M
YoY Change -103.21% -2313.58%
Cash From Investing Activities $5.151M $24.98M -$6.914M
YoY Change -102.49% -461.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.456M
YoY Change 17724.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.069M 1.110M 579.8M
YoY Change -104.59% -99.81% 2319156.0%
NET CHANGE
Cash From Operating Activities -14.91M -12.86M -20.16M
Cash From Investing Activities 5.151M 24.98M -6.914M
Cash From Financing Activities -1.069M 1.110M 579.8M
Net Change In Cash -10.83M 13.23M 552.7M
YoY Change -94.25% -97.61% 2210874.28%
FREE CASH FLOW
Cash From Operating Activities -$14.91M -$12.86M -$20.16M
Capital Expenditures $1.406M -$1.587M -$5.714M
Free Cash Flow -$16.32M -$11.27M -$14.44M
YoY Change 717.18% -21.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001824920
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39694
dei Entity Registrant Name
EntityRegistrantName
IONQ, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2992192
dei Entity Address Address Line1
EntityAddressAddressLine1
4505 Campus Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
College Park
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20740
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
298-7997
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2876000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
707000
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8134000
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
199958809
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57198000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399025000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
348435000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
123443000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6442000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
416643000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
529617000
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
150154000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
80110000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25065000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18870000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3824000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4032000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7600000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5841000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3315000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3558000
CY2022Q3 us-gaap Assets
Assets
606601000
CY2021Q4 us-gaap Assets
Assets
642028000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5042000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1882000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8177000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2647000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
582000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
568000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4700000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3430000
CY2022Q3 ionq Current Portion Of Stock Option Early Exercise Liabilities
CurrentPortionOfStockOptionEarlyExerciseLiabilities
1130000
CY2021Q4 ionq Current Portion Of Stock Option Early Exercise Liabilities
CurrentPortionOfStockOptionEarlyExerciseLiabilities
1164000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19631000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9691000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3512000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3643000
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
741000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1533000
CY2022Q3 ionq Stock Option Early Exercise Liabilities Net Of Current Portion
StockOptionEarlyExerciseLiabilitiesNetOfCurrentPortion
1122000
CY2021Q4 ionq Stock Option Early Exercise Liabilities Net Of Current Portion
StockOptionEarlyExerciseLiabilitiesNetOfCurrentPortion
1969000
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5598000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
33962000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
367000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2022Q3 us-gaap Liabilities
Liabilities
30971000
CY2021Q4 us-gaap Liabilities
Liabilities
50798000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
198914446
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
198914446
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195630975
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195630975
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
20000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
760389000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
737150000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175655000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145791000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9124000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-148000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
575630000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
591230000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
606601000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
642028000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2763000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7324000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
451000
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
733000
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
234000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2043000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
742000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13292000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6180000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30282000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15311000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1969000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1286000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5971000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2384000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10149000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2461000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26901000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8321000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1531000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
596000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4248000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1543000
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
27674000
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10757000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
69445000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
28301000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24911000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10524000
us-gaap Operating Income Loss
OperatingIncomeLoss
-62121000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27850000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1151000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-28358000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2059000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3926000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0
CY2022Q3 ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
0
CY2021Q3 ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
4259000
ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
0
ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
4259000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23983000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14781000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29864000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32102000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23983000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14781000
us-gaap Net Income Loss
NetIncomeLoss
-29864000
us-gaap Net Income Loss
NetIncomeLoss
-32102000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198301240
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198301240
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120605457
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120605457
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197255965
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6128000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
526505000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
557667000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
197255965
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119535167
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119535167
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23983000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14781000
us-gaap Net Income Loss
NetIncomeLoss
-29864000
us-gaap Net Income Loss
NetIncomeLoss
-32102000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2195000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8976000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2195000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8976000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26178000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14781000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38840000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32102000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
592678000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23983000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2195000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
386000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
282000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8461000
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
575630000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
43409000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14781000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
380000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2121000
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
526505000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
557667000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
591230000
us-gaap Net Income Loss
NetIncomeLoss
-29864000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8976000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
953000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
880000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
473000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20909000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
575630000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
53703000
us-gaap Net Income Loss
NetIncomeLoss
-32102000
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
2381000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
256000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-184000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
796000
us-gaap Profit Loss
ProfitLoss
29864000
us-gaap Profit Loss
ProfitLoss
32102000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4248000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1543000
ionq Non Cash Research And Development Arrangements
NonCashResearchAndDevelopmentArrangements
390000
ionq Non Cash Research And Development Arrangements
NonCashResearchAndDevelopmentArrangements
1205000
ionq Amortization Of Customer Warrant
AmortizationOfCustomerWarrant
0
ionq Amortization Of Customer Warrant
AmortizationOfCustomerWarrant
219000
us-gaap Share Based Compensation
ShareBasedCompensation
22561000
us-gaap Share Based Compensation
ShareBasedCompensation
5929000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-28358000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
ionq Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
0
ionq Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
4259000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
38000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1135000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3691000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1842000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3950000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2992000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1191000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1996000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1714000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-555000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4084000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
180000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
54000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29785000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21851000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8381000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5295000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1491000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1205000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
598000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
414000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
488887000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
185150000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-314207000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6914000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
953000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5424000
ionq Receipts Tax Witholding Sharebased Payment Arrangement
ReceiptsTaxWitholdingSharebasedPaymentArrangement
1212000
ionq Receipts Tax Witholding Sharebased Payment Arrangement
ReceiptsTaxWitholdingSharebasedPaymentArrangement
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
ionq Proceedsfrompublicwarrantsexercised
Proceedsfrompublicwarrantsexercised
17000
ionq Proceedsfrompublicwarrantsexercised
Proceedsfrompublicwarrantsexercised
0
ionq Repurchase Of Early Exercised Stock Options
RepurchaseOfEarlyExercisedStockOptions
0
ionq Repurchase Of Early Exercised Stock Options
RepurchaseOfEarlyExercisedStockOptions
968000
ionq Proceeds From Merger And Pipe Transaction Net Of Transaction Costs
ProceedsFromMergerAndPipeTransactionNetOfTransactionCosts
0
ionq Proceeds From Merger And Pipe Transaction Net Of Transaction Costs
ProceedsFromMergerAndPipeTransactionNetOfTransactionCosts
575483000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2165000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
579939000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-341827000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
551174000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
399025000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36120000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57198000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
587294000
ionq Issuance Of Common Stock For Intellectual Property
IssuanceOfCommonStockForIntellectualProperty
0
ionq Issuance Of Common Stock For Intellectual Property
IssuanceOfCommonStockForIntellectualProperty
1567000
ionq Issuance Of Common Stock For Research And Development Arrangement
IssuanceOfCommonStockForResearchAndDevelopmentArrangement
0
ionq Issuance Of Common Stock For Research And Development Arrangement
IssuanceOfCommonStockForResearchAndDevelopmentArrangement
814000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
186000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
309000
ionq Intangible Asset Purchases In Accounts Payable And Accrued Expenses
IntangibleAssetPurchasesInAccountsPayableAndAccruedExpenses
256000
ionq Intangible Asset Purchases In Accounts Payable And Accrued Expenses
IntangibleAssetPurchasesInAccountsPayableAndAccruedExpenses
129000
ionq Non Cash Reclassification Of Warrant Liabilities To Equity Upon Exercise
NonCashReclassificationOfWarrantLiabilitiesToEquityUponExercise
8000
ionq Non Cash Reclassification Of Warrant Liabilities To Equity Upon Exercise
NonCashReclassificationOfWarrantLiabilitiesToEquityUponExercise
0
ionq Bonus Settled In Restricted Stock Units
BonusSettledInRestrictedStockUnits
473000
ionq Bonus Settled In Restricted Stock Units
BonusSettledInRestrictedStockUnits
0
ionq Transaction Costs In Accounts Payable And Accrued Expenses
TransactionCostsInAccountsPayableAndAccruedExpenses
0
ionq Transaction Costs In Accounts Payable And Accrued Expenses
TransactionCostsInAccountsPayableAndAccruedExpenses
2620000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2876000
us-gaap Revenues
Revenues
1235000000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP and the rules and regulations of the SEC requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Significant estimates and judgments are inherent in the analysis and measurement of items including, but not limited to revenue recognition, capitalization of internally developed software and quantum computing costs, useful lives of long-lived assets, commitments and contingencies, fair value of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities, and forecasts and assumptions used in determining the fair value of historically granted common stock, stock options and warrants prior to the Business Combination. Management bases its estimates and assumptions on historical experience, expectations, forecasts, and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ and be affected by changes in those estimates. </div>
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
707000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
4963000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3875000
us-gaap Proceeds From Customers
ProceedsFromCustomers
4353000
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
5441000
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentrations of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, investments, and trade accounts receivable. The Company maintains the majority of its cash, cash equivalents and investments with two financial institutions, both of which management believes to be financially sound and with minimal credit risk. The Company’s deposits periodically exceed amounts guaranteed by the Federal Deposit Insurance Corporation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s accounts receivable are derived from customers primarily located in the United States. The Company performs periodic evaluations of its customers’ financial condition and generally does not require its customers to provide collateral or other security to support accounts receivable and maintains an allowance for doubtful accounts. Credit losses historically have not been material. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers are those which represent more than 10% </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">of the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Company’s total revenue. The Company’s revenue was primarily from three significant customers for each of the three and nine months ended September 30, 2022. The Company’s revenue was from two significant customers for the three months ended September 30, 2021, and from three customers for the nine months ended September 30, 2021. </div> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-23983000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14781000
us-gaap Net Income Loss
NetIncomeLoss
-29864000
us-gaap Net Income Loss
NetIncomeLoss
-32102000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198301240
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198301240
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120605457
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120605457
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
197255965
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197255965
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119535167
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119535167
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43307787
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34906664
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40548479
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34441773
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
564911000
CY2022Q3 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
9124000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
555787000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
602725000
CY2021Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
3000
CY2021Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
150000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
602578000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2022Q3 ionq Debt Securities Available For Sale Contractual Maturity Less Than12 Months
DebtSecuritiesAvailableForSaleContractualMaturityLessThan12Months
405633000
CY2022Q3 ionq Debt Securities Available For Sale Contractual Maturity Greater Than12 Months
DebtSecuritiesAvailableForSaleContractualMaturityGreaterThan12Months
150154000
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
555787000
CY2021Q3 ionq Warrant Amortization
WarrantAmortization
100000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31637000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22315000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6572000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3445000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25065000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18870000
CY2022Q3 us-gaap Depreciation
Depreciation
1100000
CY2021Q3 us-gaap Depreciation
Depreciation
400000
us-gaap Depreciation
Depreciation
3100000
us-gaap Depreciation
Depreciation
1000000
CY2022Q3 ionq Percentage Of Common Stock Holding
PercentageOfCommonStockHolding
0.005
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8301202
CY2020Q3 ionq Percent Of Warrant Shares Will Vest And Be Immediately Exercisable
PercentOfWarrantSharesWillVestAndBeImmediatelyExercisable
0.065
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.38
CY2022Q3 ionq Fair Value Of The Warrant Shares
FairValueOfTheWarrantShares
8700000
CY2020Q4 ionq Fair Value Of Warrants Vested
FairValueOfWarrantsVested
600000
ionq Warrant Amortization
WarrantAmortization
200000
CY2022Q3 ionq Warrant Amortization
WarrantAmortization
0
ionq Warrant Amortization
WarrantAmortization
0
CY2022Q3 ionq Class Of Warrant Or Right Issue Price
ClassOfWarrantOrRightIssuePrice
11.5
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.03
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0253
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M3D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7383
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7596
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7704
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22133210
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
377580000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3877000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2043655
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
131710
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.69
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23834845
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
88080000.00
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12054991
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y11M19D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
52240000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
23834845
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y6M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
88080000.00
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21863368
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.34
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M1D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
44790000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6492540
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.39
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3308594
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1212609
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.91
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23834705
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
227890000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1500000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
28300000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2800000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3200000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7300000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5000000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.05
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.83
CY2022Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1030469
CY2021Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1420662
CY2022Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2300000
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3100000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1025000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1656000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1622000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8177000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2647000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10493000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2121000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23696000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6128000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6521000
ionq Related Party Transaction Term
RelatedPartyTransactionTerm
P3Y
CY2022Q3 ionq Allocated Rent Expense
AllocatedRentExpense
100000
CY2021Q3 ionq Allocated Rent Expense
AllocatedRentExpense
100000
ionq Allocated Rent Expense
AllocatedRentExpense
400000
ionq Allocated Rent Expense
AllocatedRentExpense
400000

Files In Submission

Name View Source Status
0001193125-22-284614-index-headers.html Edgar Link pending
0001193125-22-284614-index.html Edgar Link pending
0001193125-22-284614.txt Edgar Link pending
0001193125-22-284614-xbrl.zip Edgar Link pending
d378202d10q.htm Edgar Link pending
d378202dex311.htm Edgar Link pending
d378202dex312.htm Edgar Link pending
d378202dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ionq-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ionq-20220930_cal.xml Edgar Link unprocessable
ionq-20220930_def.xml Edgar Link unprocessable
ionq-20220930_lab.xml Edgar Link unprocessable
ionq-20220930_pre.xml Edgar Link unprocessable
d378202d10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable